Testing effectiveness (Phase 2)Study completedNCT00222027
What this trial is testing
Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial
Who this might be right for
Acute Lymphoblastic Leukemia
University Hospital, Toulouse 300